Royalty Pharma (RPRX) Stock Highlights

24.92 | +2.64%

2024-12-21 00:47:21

Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industrys therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnsons Imbruvica, Astellas and Pfizers Xtandi, Biogens Tysabri, Johnson & Johnsons Tremfya, Gileads Trodelvy, Mercks Januvia, Novartis Promacta, Vertexs Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates.

Statistics

Range Today

24.32 25

Volume Today 7.57M

Range 1 Year

24.05 31.66

Volume 1 Year 666.25M

Range 3 Year

24.05 44.75

Volume 3 Year 1.67B

Range 10 Year

24.05 56.5

Volume 10 Year 2.54B

Highlights

Market Capitalization 15.44B (large)

Floating Shares 384.39M

Current Price 24.92

Price To Earnings 10.48

Price To Revenue 9.61

Price To Book 1.7

Earnings Per Share 2.54

Dividend Yield 3.17%

Dividend Per Share 0.84

Payout Ratio 32.68%

Performance

Latest +2.64%

1 Month -4.48%

3 Months -11.54%

6 Months -5.25%

1 Year -10.42%

3 Years -34.68%

5 Years -43.36%

10 Years -43.36%

Benchmarks

Market Capitalization

8 / 368

Gross Profits

10 / 278

Total Revenue

6 / 300

Total Rank

38 / 368

Free Cashflow

350 / 352

Performance 5 years

163 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.